Procter & Gamble Health Stock

Procter & Gamble Health EBIT

The EBIT of Procter & Gamble Health (PGHL.NS) as of Aug 4, 2026 is 3.04 B INR. In the previous year, EBIT was 2.82 B INR — a change of 8.01% (higher).

EBIT

3.04 BINR

YoY

8.01%

Last updated:

In 2026, Procter & Gamble Health's EBIT was 3.04 B INR, a 8.01% increase from the 2.82 B INR EBIT recorded in the previous year.

The Procter & Gamble Health EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (B INR)
Date
EBIT (B INR)
Jan 1, 2021
2.17 base
Jan 1, 2022
2.47 base
Jan 1, 2023
3.09 base
Jan 1, 2024
2.82 base
Jan 1, 2025
3.04 base
Jan 1, 2026 (e)
3.52 base
Jan 1, 2027 (e)
4.06 base
Jan 1, 2028 (e)
4.60 base
YEAREBIT (B INR)
2028 est 4.60
2027 est 4.06
2026 est 3.52
2025 3.04
2024 2.82
2023 3.09
2022 2.47
2021 2.17
2020 2.90
2019 2.41
2018 1.26
2017 0.75
2016 0.99
2015 0.61
2014 0.46
2013 0.67
2012 0.97
2011 0.65
2010 0.70
2009 0.53
2008 0.44
2007 0.60
2006 -0.02
Access this data via the Eulerpool API

Procter & Gamble Health Revenue

Procter & Gamble Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
10.09 B INR
2.17 B INR
1.77 B INR
Jan 1, 2022
11.14 B INR
2.47 B INR
1.93 B INR
Jan 1, 2023
12.30 B INR
3.09 B INR
2.29 B INR
Jan 1, 2024
11.51 B INR
2.82 B INR
2.01 B INR
Jan 1, 2025
9.34 B INR
3.04 B INR
2.34 B INR
Jan 1, 2026 (e)
13.52 B INR
3.52 B INR
3.15 B INR
Jan 1, 2027 (e)
15.60 B INR
4.06 B INR
3.74 B INR
Jan 1, 2028 (e)
17.68 B INR
4.60 B INR
4.26 B INR

Procter & Gamble Health Margins

Procter & Gamble Health stock margins

The Procter & Gamble Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Procter & Gamble Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Procter & Gamble Health.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
65.81 %
21.54 %
17.53 %
Jan 1, 2022
63.13 %
22.20 %
17.27 %
Jan 1, 2023
63.63 %
25.12 %
18.66 %
Jan 1, 2024
64.50 %
24.46 %
17.46 %
Jan 1, 2025
66.01 %
32.56 %
25.09 %
Jan 1, 2026 (e)
66.01 %
26.05 %
23.32 %
Jan 1, 2027 (e)
66.01 %
26.05 %
23.98 %
Jan 1, 2028 (e)
66.01 %
26.05 %
24.07 %

Procter & Gamble Health Stock analysis

What does Procter & Gamble Health do? Procter & Gamble Health Ltd. is a leading company in the health and hygiene products industry. The company was founded in 1837 by William Procter and James Gamble in Cincinnati, Ohio. Since then, the company has undergone incredible development and is now a global corporation with more than 95,000 employees and an annual revenue of nearly $70 billion. The business model of Procter & Gamble Health Ltd. is focused on providing customers with high-quality products at an affordable price. The company operates in various areas, including household products, health products, beauty products, and hygiene products. The different divisions of Procter & Gamble Health Ltd. include the following areas: Household products: Brands like Ariel, Ace, and Lenor are among the most well-known offerings from Procter & Gamble Health. The company is also active in the textile care category and offers various products such as the brand Downy. Health products: The company's health products focus on oral and dental care, as well as pain relief and digestive aids. Brands like Oral-B and Vick are among the most well-known in the portfolio. Beauty products: Procter & Gamble Health offers a wide range of beauty products such as shampoo, conditioner, and hair dye. Herbal Essences, Pantene, and Wella are among the most well-known brands in this area. Hygiene products: The company offers products such as toilet paper, diapers, and cleaning agents. Pampers, Charmin, and Swiffer are among the most well-known brands. Procter & Gamble Health Ltd. has a very extensive product portfolio, which also includes brands like Always, Old Spice, and Gillette. Procter & Gamble Health is an innovative company that continuously offers its customers new and improved products. An example of this is the development of Tide Pods, a novel way to wash laundry that is packaged in a completely soluble shell. In addition to continuous product development, the company also places great importance on sustainability and social responsibility. Procter & Gamble Health actively engages in environmental protection and advocates for the improvement of working conditions and quality of life for people worldwide. In summary, Procter & Gamble Health Ltd. is a successful company that enjoys an excellent reputation due to its innovative strength, extensive product range, and commitment to sustainability and social responsibility. Procter & Gamble Health is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Procter & Gamble Health's EBIT

Procter & Gamble Health's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Procter & Gamble Health's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Procter & Gamble Health's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Procter & Gamble Health’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Procter & Gamble Health stock

EBIT of Procter & Gamble Health is 3.04 B INR in 2026.

EBIT of Procter & Gamble Health changed from 2.82 B INR to 3.04 B INR, representing a 8.01% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Procter & Gamble Health since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Procter & Gamble Health historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Procter & Gamble Health

All Key Metrics — Procter & Gamble Health